EX-13 3 dex13.txt REGISTRANT'S 2001 ANNUAL REPORT TO STOCKHOLDERS Exhibit 13 Registrant's 2001 Annual Report To Shareholders Financial Highlights:
Three months Fiscal Year Fiscal Year Ended ended Ended ------------------------------------------------------------------------------------------------- Income Statement Data (in thousands, except share June 30, 2001 June 30, 2000 June 30, 1999 June 30, 1998 June 30, 1997 March 28, 1997 and per share data) (1) ------------------------------------------------------------------------------------------------------------------------------- Net sales $1,645,993 $1,458,047 $ 815,319 $ 612,427 $ 144,473 $ 479,524 Gross profit 68,824 56,422 41,536 30,654 6,076 22,810 Income from operations 26,946 22,299 14,842 9,770 1,363 5,617 Net income $ 9,144 $ 8,199 $ 6,625 $ 3,942 $ 400 $ 1,461 Basic earnings per share $ 2.16 $ 1.93 $ 1.72 $ 1.18 $ 0.13 $ 0.48 Diluted earnings per share $ 2.02 $ 1.84 $ 1.58 $ 1.07 $ 0.12 $ 0.44 Basic common shares outstanding 4,239,099 4,240,951 3,846,837 3,345,261 3,054,994 3,033,536 Diluted common shares outstanding 4,565,757 4,549,876 4,219,876 3,766,352 3,626,831 3,588,943 Pro Forma (unaudited) Balance Sheet Data June 30, June 30, 2001 June 30, 2000 June 30, 1999 June 30, 1998 March 28, 1997 (in thousands) 2001 (2) (1) --------------------------------------------------------------------------------------------------------------------------- Current assets $272,984 $270,050 $237,494 $181,824 $153,513 $ 81,901 Working capital 98,803 97,533 93,556 28,525 60,549 31,239 Total assets 339,271 330,204 294,419 236,990 178,371 108,034 Long-term debt 20,862 94,489 99,647 40,449 61,156 41,530 Stockholders' equity 138,540 57,510 45,265 40,887 20,719 12,988
(1) Fiscal year changed to June 30 (2) Reflects net proceeds from the sale of 2,445,797 shares of common stock in a public offering as well as the issuance of 180,000 shares of common stock in exchange for an additional 18% equity stake in Pharmaceutical Buyers, Inc. The public offering was completed July 5, 2001 Price Range Per Common Share: The Company's common stock (symbol: "DKWD") is traded on the NASDAQ national market. The number of beneficial holders of the Company's common stock is approximately 4,000. Set forth below are the high and low transaction prices as reported by the NASDAQ stock market for the periods indicated. Such prices reflect interdealer prices, without retail markup, markdown, or commission: 2001 Low High First Quarter $ 9.38 $14.50 Second Quarter 11.50 16.00 Third Quarter 13.63 22.19 Fourth Quarter 18.44 37.05 2000 Low High First Quarter $22.13 $25.88 Second Quarter 13.50 24.00 Third Quarter 10.50 18.00 Fourth Quarter 7.50 12.25 CORPORATE OFFICES: D&K Healthcare Resources, Inc. 8000 Maryland Ave. Suite 920 St. Louis, Missouri 63105 (888) 727-3485 (314) 727-3485 Fax: (314) 727-5759 web: www.dkwd.com TRANSFER AGENT REGISTRAR: Computershare Investor Services LLC 2 North Lasalle Street Chicago, Illinois 60602 (312) 588-4700 AUDITORS: Arthur Andersen LLP St. Louis, Missouri COUNSEL: Armstrong Teasdale LLP St. Louis, Missouri FORM 10-K: Copies of form 10-K filed by D&K Healthcare Resources, Inc. for the year ended June 30, 2001, are available without charge upon request. Requests should be directed to the Company's corporate office address, marked attention: Investor Relations. ANNUAL MEETING: The annual meeting of stockholders will be held at 10:00 a.m. Wednesday, November 14, 2001, in The Ritz-Carlton, 100 Carondelet Plaza, St. Louis, MO.